Cargando…

In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability

Detalles Bibliográficos
Autores principales: Casagrande, Naike, Borghese, Cinzia, Aldinucci, Donatella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719077/
https://www.ncbi.nlm.nih.gov/pubmed/34498447
http://dx.doi.org/10.3324/haematol.2021.279389
_version_ 1784624862502846464
author Casagrande, Naike
Borghese, Cinzia
Aldinucci, Donatella
author_facet Casagrande, Naike
Borghese, Cinzia
Aldinucci, Donatella
author_sort Casagrande, Naike
collection PubMed
description
format Online
Article
Text
id pubmed-8719077
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-87190772022-01-14 In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability Casagrande, Naike Borghese, Cinzia Aldinucci, Donatella Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-09-09 /pmc/articles/PMC8719077/ /pubmed/34498447 http://dx.doi.org/10.3324/haematol.2021.279389 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letters to the Editor
Casagrande, Naike
Borghese, Cinzia
Aldinucci, Donatella
In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability
title In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability
title_full In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability
title_fullStr In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability
title_full_unstemmed In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability
title_short In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability
title_sort in classical hodgkin lymphoma the combination of the ccr5 antagonist maraviroc with trabectedin synergizes, enhances dna damage and decreases three-dimensional tumor-stroma heterospheroid viability
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719077/
https://www.ncbi.nlm.nih.gov/pubmed/34498447
http://dx.doi.org/10.3324/haematol.2021.279389
work_keys_str_mv AT casagrandenaike inclassicalhodgkinlymphomathecombinationoftheccr5antagonistmaravirocwithtrabectedinsynergizesenhancesdnadamageanddecreasesthreedimensionaltumorstromaheterospheroidviability
AT borghesecinzia inclassicalhodgkinlymphomathecombinationoftheccr5antagonistmaravirocwithtrabectedinsynergizesenhancesdnadamageanddecreasesthreedimensionaltumorstromaheterospheroidviability
AT aldinuccidonatella inclassicalhodgkinlymphomathecombinationoftheccr5antagonistmaravirocwithtrabectedinsynergizesenhancesdnadamageanddecreasesthreedimensionaltumorstromaheterospheroidviability